Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Colin Kit Lun Phoon has a total of 182 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pyrophosphatase 2 Deficiency: Clinical Presentation, Diagnosis and Management

    by Hayley Nehoff, Ian Crozier, Hilary Vernon, Christine James, Ana I. Fernández-Ávila, Michael Bowes, Esther Gomez-Gonzalez, Colin Phoon, Kristy DiLoreto, Martin E. Matsumura, et al.

    BACKGROUND: PPA2 (pyrophosphatase 2) deficiency is a relatively newly recognized condition caused by biallelic variants in the PPA2 gene. The gene encodes the mitochondrial enzyme PPA2, involved in the production of orthophosphate in the mitochondrial matrix. Affected individuals typically present with sudden cardiac death or acute heart failure following common viral illnesses in infants and toddlers, or following exposure to small amounts of alcohol as teenagers. The condition has a high mortality rate in these situations. Here, we explore the clinical presentations and current management of these patients with a view to guiding future emergency clinical management of cases. METHODS: Case records from published and unpublished affected individuals diagnosed with PPA2 deficiency were compiled in a retrospective cohort study of genotypes, phenotypes and clinical management protocols in individuals with biallelic (likely) pathogenic PPA2 variants. RESULTS: We collated 93 affected individuals from 53 families, 14 of which have not previously been reported. Patient presentation is invariably acute, often associated with fatigue, vomiting, seizures and collapse. Generally, presenting individuals received standard emergency management with cardiopulmonary resuscitation and appropriate management of arrhythmia, and here we present compiled clinical management protocols for emergency and ongoing treatment of PPA2-deficient patients. A pronounced inheritance rate of pathogenic alleles from carrier parents is noted, and further research is warranted to confirm and investigate any selective advantage for gametes carrying pathogenic PPA2 variants. CONCLUSIONS: PPA2 deficiency has a high mortality rate following exposure to common childhood viruses in children around and under the age of 3 and in teenagers exposed to ethanol. We have presented current therapeutic approaches gathered from a worldwide survey of clinicians treating their patients, possible pathogenic mechanisms and inheritance peculiarities of the condition and provide a comprehensive review of the current recommendations surrounding patients’ clinical management.

  • Open Access

    De novo synthesis of cardiolipin controls respiratory chain biogenesis in neonatal mouse hearts

    by Mindong Ren, Yang Xu, Colin K L Phoon, Hediye Erdjument-Bromage, Thomas A Neubert, Michael Schlame

    Postnatal maturation of the mammalian heart requires a vast increase in respiratory enzymes. The mitochondria-specific lipid cardiolipin (CL) is essential for respiratory chain integrity but has no defined function in heart maturation. Here, we determined how the two steps of CL biogenesis, de novo synthesis and acyl chain remodeling, affect the maturation of cardiac mitochondria in mice. Cardiomyocyte-restricted deletion of the CL synthase Crls1 in late gestation does not affect CL levels at birth but blocks the increase in the tissue concentration of CL observed during normal postnatal maturation. Deletion of Crls1 prevents the postnatal rise in cristae density and in the intramitochondrial concentration of respiratory proteins. This inhibits cardiac development, precipitates heart failure, and causes death by the age of 2 weeks. In contrast, ablation of CL remodeling by cardiomyocyte-restricted deletion of Tafazzin does not disrupt mitochondrial maturation or cardiac development, although it has a similar effect on the CL concentration and profoundly alters the CL species composition. Our data show that CL synthesis, but not CL remodeling, controls expression of the respiratory chain by a mechanism independent of the CL concentration.


  • Open Access

    LPLAT7 reutilizes unsaturated 1-lysophospholipids formed during lysosomal phospholipid degradation

    by Yang Xu, Sujith Rajan, Colin K.L. Phoon, Mindong Ren, M. Mahmood Hussain, Michael Schlame

  • Open Access

    Survival and Clinical Progression in Barth Syndrome: Insights From the Barth Syndrome Foundation's Database of 502 Affected Individuals

    by Kexin Fu, Yonglin Huang, Valerie Bowen, Katherine McCurdy, Reina B. Tan, Colin K. L. Phoon, Lindsay Marjoram, Alex Dahlen

    Barth syndrome (BTHS; OMIM 302060) is an ultra‐rare, life‐limiting genetic disorder characterized by cardiomyopathy, skeletal muscle myopathy, neutropenia, gastrointestinal issues, and fatigue. Formal analyses of survival and clinical progression remain limited. Barth Syndrome Foundation has maintained an intake database ( n = 502), representing > 80% of the known global population, as well as a patient‐inputted registry for a subset of individuals ( n = 162) with up to 11 years of longitudinal outcome data. We estimate the survival curve, identify factors associated with mortality, characterize clinical manifestations over time, and evaluate causes of death. Death disproportionately affected young children, with a 59% transplant‐free survival rate for those age < 5. The risk of death plateaued between ages 5–25 before rising again. Heart transplantation (HR = 0.316, 95% CI: 0.162–0.619, p < 0.001) and living in a developed country (HR = 0.109, 95% CI: 0.018–0.659, p < 0.05) were associated with reduced risk of death. Clinical manifestations increased with age, with musculoskeletal/fatigue (66%) being most frequent. Top causes of death were cardiac‐related complications, with cardiomyopathy/heart failure (51.3%), mostly in young children < 5, and arrhythmia/cardiac arrest (15%). This is the most comprehensive longitudinal assessment of BTHS survival, mortality risk, and clinical manifestation progression. Early childhood is a period of high mortality risk, driven in large part by heart failure. Although risk of death and hospitalizations plateaued between ages 5–25, the clinical burden of BTHS increases throughout the lifespan. Our results may guide clinical care, identify time windows for optimal intervention, and help clinicians better recognize BTHS clinical features.


  • Open Access

    StaBle: Staggered PRF With DouBle Transmission for Increasing the Velocity Limit of High-Frame-Rate Vector Doppler Imaging

    by Geraldi Wahyulaksana, Colin K. L. Phoon, Glenn I. Fishman, Jeffrey A. Ketterling

    Vector Doppler Imaging (VDI) addresses the limitations of traditional Doppler imaging by measuring blood flow in axial and lateral directions but will produce incorrect results if aliasing is present. Aliasing becomes more likely when using high transmit frequencies such as in small animal cardiac applications. The use of multiple transmit angles decreases the Nyquist limit, which further increases the likelihood of aliasing. A new transmission scheme, termed StaBle, is proposed to increase the Nyquist limit of conventional sequential angle VDI by multiple fold. StaBle combines the velocity limit extension of staggered multiple pulse repetition frequency (PRF) with a double transmission scheme. With three transmit angles and two PRFs, StaBle was able to achieve a 6-12 times higher velocity limit compared to sequential angle VDI. Simulation and phantom spinning disk experiments were conducted to evaluate StaBle’s performance. The simulation results showed a normalized root-mean-squared error of less than 5% compared to an ideal vector field in both axial and lateral directions. Phantom results showed a 9-fold improvement in detecting peak axial velocity over sequential three angle VDI. The ability of StaBle to obtain an unaliased vector field in vivo was demonstrated by imaging a mouse left ventricle where the Doppler signal was corrupted by aliasing artifacts using just a double transmit scheme. The resolved estimated vector velocity showed consistent beat-to-beat variation in velocity, confirming StaBle’s robustness under realistic conditions and its potential for use in investigative studies.


  • Mouse Cardiovascular Imaging

    by Colin K.L. Phoon, Orlando Aristizábal, Mohammed Farhoud, Daniel H. Turnbull, Youssef Z. Wadghiri

    The mouse is the mammalian model of choice for investigating cardiovascular biology, given our ability to manipulate it by genetic, pharmacologic, mechanical, and environmental means. Imaging is an important approach to phenotyping both function and structure of cardiac and vascular components. This review details commonly used imaging approaches, with a focus on echocardiography and magnetic resonance imaging, with brief overviews of other imaging modalities. In this update, we also emphasize the importance of rigor and reproducibility in imaging approaches, experimental design, and documentation. Finally, we briefly outline emerging imaging approaches but caution that reliability and validity data may be lacking. © 2024 Wiley Periodicals LLC.


  • Open Access

    A Pregnant Adolescent with COVID-19 and Multisystem Inflammatory Syndrome in Children

    by Megan E. Trostle, Tracy B. Grossman, Christina A. Penfield, Colin K. L. Phoon, Vanessa N. Raabe, Mark F. Sloane, Ashley S. Roman

    Multisystem inflammatory syndrome in children (MIS-C), a new condition related to coronavirus disease 2019 (COVID-19) in the pediatric population, was recognized by physicians in the United Kingdom in April 2020. Given those up to the age of 21 years can be affected, pregnant adolescents and young adults are susceptible. However, there is scant information on how MIS-C may affect pregnancy and whether the presentation differs in the pregnant population. We report a case of a pregnant adolescent with COVID-19 and MIS-C with a favorable outcome. This case highlights the considerations in managing a critically ill pregnant patient with a novel illness and the importance of a multidisciplinary team in coordinating care.

  • Open Access

    Cardiolipin prolongs the lifetimes of respiratory proteins in Drosophila flight muscle

    by Mindong Ren, Yang Xu, Colin K.L. Phoon, Hediye Erdjument-Bromage, Thomas A. Neubert, Michael Schlame